Aging
Navigate
Editorial|Volume 11, Issue 20|pp 8743—8744

CD38-NAD+-Sirt1 axis in T cell immunotherapy

Shilpak Chatterjee1, Paramita Chakraborty2, Shikhar Mehrotra2
  • 1Indian Institute of Chemical Biology, TRUE Campus, Kolkata 700091, India
  • 2Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA
Received: June 24, 2019Accepted: October 3, 2019Published: October 23, 2019

Copyright © 2019 Chatterjee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.